Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onset of Action of GW685698X in Seasonal Allergic Rhinitis
NCT00118729Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2005
- Primary completion
- Aug 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing GW685698X with Placebo (2 arms). Primary endpoint: Total Nasal Symptom Score at 12 hours. Started Apr 2005; status: completed.
02
Drugs
fluticasone
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00118729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00118729.